Search - tctmd.com

Displaying 501 - 520 of 851

Sort: Relevancy | Date

News Conference News CRT 2017

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Michael O'Riordan

February 27, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

Presentation JIM 2017

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Presenter: Alberto Cremonesi

February 10, 2017

Presentation JIM 2017

Mitraclip Evolution: Where Do We Stand? The New Frontiers in Mitral Valve Repair and Replacement

Presenter: Fausto Castriota

February 10, 2017

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

Presentation

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

February 09, 2017

Presentation

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

Presenter: Jeffrey Popma

February 09, 2017

Presentation JIM 2017

“Evolution of TAVI: transfemoral outcomes using ACURATE neo”

Presenter: Corrado Tamburino

February 09, 2017

News Daily News

Transfemoral PCI More Successful in Treating CTOs, Especially Complex Lesions

Yael L. Maxwell

February 07, 2017

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

Presentation CHIP Florida 2017

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Presenter: David E. Kandzari

January 20, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies

January 17, 2017

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

Presentation TCT 2016

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Jeffrey J. Popma

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Presenter: Ron Waksman, Robert-Jan van Geuns, Michael Haude

October 31, 2016

Presentation TCT 2016

The FDA Town Hall Meeting: Evolution of a Decades Long Collaboration Between Physician-Scientists, Industry, Regulators, and Payors

Presenter: Matthew G. Hillebrenner, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Presenter: Lutz Buellesfeld, Raj Makkar, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

Advertisement

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Mitraclip Evolution: Where Do We Stand? The New Frontiers in Mitral Valve Repair and Replacement

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Initial Experience of Second-Generation Self-Expandable TAVR System (Evolut R)

Early Clinical Outcomes with Self-Expandable TAVR System (Evolut R) in Severe AS

“Evolution of TAVI: transfemoral outcomes using ACURATE neo”

Transfemoral PCI More Successful in Treating CTOs, Especially Complex Lesions

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

The FDA Town Hall Meeting: Evolution of a Decades Long Collaboration Between Physician-Scientists, Industry, Regulators, and Payors

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content